PubMed COVID-19 Clinical Care
13801 - 13810 of 44979 results found
Estimation of waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics
Description
Monitoring time-varying vaccine effectiveness (e.g., due to waning of immunity and the emergence of novel variants) provides crucial information for outbreak control. Existing studies of time-varying vaccine effectiveness have used individual-level
C-reactive protein and the neutrophil-to-lymphocyte ratio on admission predicting bacteraemia with COVID-19
Description
CONCLUSIONS: Considering the possibility of the co-occurrence of bacteraemia with COVID-19, a blood culture should be performed when CRP is ≥ 6.3 or the NLR is ≥ 7.7.
Impact of COVID-19-related clinic closures on HIV incidence in a multicentre study of young adult MSM and transgender women in Kenya
Description
CONCLUSIONS: HIV incidence during COVID-19-related clinic closures was moderately increased and reduced after COVID-19 restrictions were eased. Ensuring access to services for key populations is important during public health emergencies.
Convalescent Plasma Lowered Risk of Death in COVID-19 ARDS
Description
No abstract
Malnutrition in COVID-19 survivors: comment
Description
No abstract
Relationships Between Mental Health, Negative Feelings of COVID-19, and Parenting Among Pregnant Women in Fortaleza, Brazil
Description
INTRODUCTION: During the COVID-19 pandemic, the literature highlighted an increased risk of child abuse and the use of negative parenting practices. Furthermore, pregnancy during this time may have been challenging and generated different feelings
Regional anaesthesia for ambulatory surgery
Description
Regional anaesthesia (RA) has an important and ever-expanding role in ambulatory surgery. Specific practices vary depending on the preferences and resources of the anaesthesia team and hospital setting. It is used for various purposes, including as
The value of observational registry studies for the next infectious disease emergency
Description
During infectious disease emergencies, it may be necessary to deploy new therapies without conclusive evidence for their effectiveness. During the SARS-CoV-2 pandemic, several countries used registries to track the use of COVID-19 convalescent plasma
In Reference to Otolaryngologic Side Effects After COVID-19 Vaccination
Description
No abstract
